Anti-cancer drug axitinib: a unique tautomerism-induced dual-emissive probe for protein analysis.
Chemical communications (Cambridge, England)（2024）
摘要
A commercial anti-cancer drug, axitinib, exhibits very stable dual emissions for discrimination of human serum albumin.
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要